Cooperation between VEGF and TNF-α is necessary for exposure of active tissue factor on the surface of human endothelial cells

Arteriosclerosis, Thrombosis, and Vascular Biology

Volumn 19, Issue 3, 1999, Pages 531-537

  Camera, Marina ^a   Giesen, Peter L A ^b   Fallon, Jay ^c   Aufiero, Barbara M ^d   Taubman, Mark ^e   Tremoli, Elena ^a   Nemerson, Yale ^b  

^a UNIVERSITY OF MILAN   (Italy)

^b Division of Thrombosis Research   (United States)

^c Departments of Pathology and Medicine   (United States)

^d Derald H Ruttenberg Cancer Center   (United States)

^e MOUNT SINAI SCHOOL OF MEDICINE   (United States)

Author keywords

Cytokines; Endothelium; Factor Xa generation; Growth factors; Procoagulant activity

Indexed keywords

BLOOD CLOTTING FACTOR 10A; MESSENGER RNA; RECOMBINANT TUMOR NECROSIS FACTOR ALPHA; RECOMBINANT VASCULOTROPIN; THROMBOPLASTIN;

ARTICLE; BLOOD CLOTTING; CONTROLLED STUDY; COOPERATION; ENDOTHELIUM CELL; HUMAN; HUMAN CELL; PRIORITY JOURNAL; UMBILICAL VEIN;

EID: 0032975660     PISSN: 10795642     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.ATV.19.3.531     Document Type: Article

References (49)

1. Nemerson Y. Tissue factor and hemostasis. Blood. 1988;71:1-8.
2. Drake TA, Ruf W, Morrissey JH, Edgington TS. Functional tissue factor is entirely cell surface expressed on lipopolysaccharide-stimulated human blood monocytes and a constitutively tissue factor-producing neoplastic cell line. J Cell Biol. 1989;109:389-395.
3. Fleck RA, Rao LV, Rapaport SI, Varki N. Localization of human tissue factor antigen by immunostaining with monospecific, polyclonal anti-human tissue factor antibody [corrected and republished article originally printed in Thromb Res. 1990;57:765-781]. Thromb Res. 1990;59: 421-437.
4. Faulk WP, Labarrere CA, Carson SD. Tissue factor: identification and characterization of cell types in human placentae. Blood. 1990;76:86-96.
5. Bevilacqua MP, Pober JS, Majeau GR, Cotran RS, Gimbrone M Jr. Interleukin 1 (IL-1) induces biosynthesis and cell surface expression of procoagulant activity in human vascular endothelial cells. J Exp Med. 1984;160:618-623.
6. Brox JH, Osterud B, Bjorklid E, Fenton JD. Production and availability of thromboplastin in endothelial cells: the effects of thrombin, endotoxin and platelets. Br J Haematol. 1984;57:239-246.
7. Bevilacqua MP, Pober JS, Majeau GR, Fiers W, Cotran RS, Gimbrone MA. Recombinant tumor necrosis factor induces procoagulant activity in cultured human vascular endothelium: characterization and comparison with the action of interleukin 1. Proc Natl Acad Sci U S A. 1986;83: 4533-4537.
8. Conway EM, Bach R, Rosenberg RD, Konigsberg WH. Tumor necrosis factor enhances expression of tissue factor mRNA in endothelial cells. Thromb Res. 1989;53:231-241.
9. Crossman DC, Carr DP, Tuddenham EG, Pearson JD, McVey JH. The regulation of tissue factor mRNA in human endothelial cells in response to endotoxin or phorbol ester. J Biol Chem. 1990;265:9782-9787.
10. Fei H, Berliner JA, Parhami F, Drake TA. Regulation of endothelial cell tissue factor expression by minimally oxidized LDL and lipopolysaccharide. Arterioscler Thromb. 1993;13:1711-1717.
11. Brand K, Fowler BJ, Edgington TS, Mackman N. Tissue factor mRNA in THP-1 monocytic cells is regulated at both transcriptional and posttranscriptional levels in response to lipopolysaccharide. Mol Cell Biol. 1991; 11:4732-4738.
12. Mackman N, Brand K, Edgington TS. Lipopolysaccharide-mediated transcriptional activation of the human tissue factor gene in THP1 monocytic cells requires both activator protein 1 and nuclear factor κB binding sites. J Exp Med. 1991;174:1517-1526.
13. Clauss M, Gerlach M, Gerlach H, Brett J, Wang F, Familletti PC, Pan Y-CE, Olander JV, Connolly DT, Stem D. Vascular permeability factor. A tumor-derived polypeptide that induces endothelial cell and monocyte procoagulant activity, and promotes monocyte migration. J Exp Med. 1990;172:1535-1545.
14. Clauss M, Murray JC, Vianna M, de Waal R, Thurston G, Nawroth P, Gerlach H, Bach R, Familletti PC, Stern D. A polypeptide factor produced by fibrosarcoma cells that induces endothelial tissue factor and enhances the procoagulant response to tumor necrosis factor/cachectin. J Biol Chem. 1990;265:7078-7083.
15. Bona R, Lee E, Rickles F. Tissue factor apoprotein: intracellular transport and expression in shed membrane vesicles. Thromb Res. 1987;48: 487-500.
16. Conkling PR, Greenberg CS, Weinberg JB. Tumor necrosis factor induces tissue factor-like activity in human leukemia cell line U937 and peripheral blood monocytes. Blood. 1988;72:128-133.
17. Andoh K, Pettersen KS, Filion-Myklbust C, Prydz H. Observation on the cell biology of tissue factor in endothelial cells. Thromb Haemost. 1990; 63:298-302.
18. Ryan J, Brett J, Tijburg P, Bach RR, Kisiel W, Stern D. Tumor necrosis factor-induced endothelial tissue factor is associated with subendothelial matrix vesicles but is not expressed on the apical surface. Blood. 1992; 80:966-974.
19. Kirchhofer D, Tschopp TB, Hadvary P, Baumgartner HR. Endothelial cells stimulated with tumor necrosis factor-α express varying amounts of tissue factor resulting in inhomogeneous fibrin deposition in a native blood flow system: effects of thrombin inhibitors. J Clin Invest. 1994; 93:2073-2083.
20. Ahern SM, Miyata T, Sadler JE. Regulation of human tissue factor expression by mRNA turnover. J Biol Chem. 1993;268:2154-2159.
21. Parry GC, Mackman N. Transcriptional regulation of tissue factor expression in human endothelial cells. Arterioscler Thromb Vasc Biol. 1995;15:612-621.
22. Moll T, Czyz M, Holzmuller H, Hofer-Warbinek R, Wagner E, Winkler H, Bach FH, Hofer E. Regulation of the tissue factor promoter in endothelial cells: binding of NF κB-, AP-1-, and Sp1 -like transcription factors. J Biol Chem. 1995;270:3849-3857.
23. Miletich J, Broze GJ Jr, Majerus PW. The synthesis of sulfated dextran beads for isolation of human plasma coagulation factors II, IX, and X. Anal Biochem. 1980;105:304-310.
24. Tremoli E, Camera M, Maderna P, Sironi L, Prati L, Colli S, Piovella F, Bernini F, Corsini A, Mussoni L. Increased synthesis of plasminogen activator inhibitor-1 by cultured human endothelial cells exposed to native and modified LDLs: an LDL receptor-independent phenomenon. Arterioscler Thromb. 1993;13:338-346.
25. Maciag T, Cerundolo J, Ilsley S, Kelley PR, Forand R. An endothelial cell growth factor from bovine hypothalamus: identification and partial characterization. Proc Natl Acad Sci U S A. 1979;76:5674-5678.
26. Tremoli E, Eligini S, Colli S, Maderna P, Rise' P, Pazzucconi F, Marangoni F, Sirtori CR, Galli C. n-3 Fatty acid ethyl ester administration to healthy subjects and to hypertriglyceridemic patients reduces tissue factor activity in adherent monocytes. Arterioscler Thromb. 1994;14: 1600-1608.
27. Bradford MM. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal Biochem. 1976;72:248-254.
28. Thiruvikraman S, Guha A, Roboz J, Taubman M, Nemerson Y, Fallon J. In situ localization of tissue factor in human atherosclerotic plaques by binding of digoxigenin-labeled factors VIIa and X. Lab Invest. 1996;75: 451-461.
29. Schecter AD, Giesen PL, Taby O, Rosenfield CL, Rossikhina M, Fyfe BS, Kohtz DS, Fallon JT, Nemerson Y, Taubman MB. Tissue factor expression in human arterial smooth muscle cells: TF is present in three cellular pools after growth factor stimulation. J Clin Invest. 1997;100: 2276-2285.
30. Diquelou A, Dupouy D, Gaspin D, Constans J, Sie P, Boneu B, Sakariassen KS, Cadroy Y. Relationship between endothelial tissue factor and thrombogenesis under blood flow conditions. Thromb Haemost. 1995;74:778-783.
31. Grabowski EF, Zuckerman DB, Nemerson Y. The functional expression of tissue factor by fibroblasts and endothelial cells under flow conditions. Blood. 1993;81:3265-3270.
32. Chomczynski P, Sacchi N. Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. Anal Biochem. 1987;162:156-159.
33. Marmur JD, Rossikhina M, Guha A, Fyfe B, Friedrich V, Mendlowitz M, Nemerson Y, Taubman MB. Tissue factor is rapidly induced in arterial smooth muscle after balloon injury. J Clin Invest. 1993;91:2253-2259.
34. Sambrook J, Fritsch EF, Maniatis T, eds. Molecular Cloning: A Laboratory Manual. Cold Spring Harbor, New York: Cold Spring Harbor Laboratory; 1989.
35. Nemerson Y, Bach R. Tissue factor revisited. Prog Thromb Hemost. 1982;6:237-262.
36. Hetland O, Brovold AB, Holme R, Gaudermack G, Prydz H. Thromboplastin (tissue factor) in plasma membranes of human monocytes. Biochem J. 1985;228:735-743.
37. Dvorak HF, Vandewater L, Blitzer AM, Dvorak AM, Anderson D, Harvey VS, Bach R, Davis GL, Dewolf W, Carvalho ACA. Procoagulant activity associated with plasma membrane vesicles shed by cultured tumor cells. Cancer Res. 1983;43:4334-4342.
38. Mulder AB, Hegge-Paping KS, Magielse CP, Blom NR, Smit JW, van der Meer J, Hallie MR, Bom VJ. Tumor necrosis factor α-induced endothelial tissue factor is located on the cell surface rather than in the subendothelial matrix. Blood. 1994;84:1559-1566.
39. Narahara N, Enden T, Wiiger M, Prydz H. Polar expression of tissue factor in human umbilical vein endothelial cells. Arterioscler Thromb. 1994;14:1815-1820.
40. Ryan J, Brett J, Tijburg P, Bach RR, Kisiel W, Stern D. Tumor necrosis factor-induced endothelial tissue factor is associated with subendothelial matrix vesicles but is not expressed on the apical surface. Blood. 1992; 80:966-974.
41. Sevinsky JR, Mohan Rao LV, Ruf W. Ligand-induced protease receptor translocation into caveolae: a mechanism for regulating cell surface proteolysis of tissue factor-dependent coagulation pathway. J Cell Biol. 1996;133:293-304.
42. Mulder AB, Smit JW, Bom VJJ, Blom NR, Ruiters MHJ, Halio MR, van der Meer J. Association of smooth muscle cell tissue factor with caveolae. Blood. 1996;88:1306-1313.
43. Raposo G, Dunia I, Marullo S, Andre C, Guillet J, Strosberg AD, Benedetti E, Hoebeke J. Redistribution of muscarinic acetylcholine receptors on human fibroblasts induced by regulatory ligands. Biol Cell. 1987;60:117-124.
44. Kagawa H, Komiyama Y, Nakamura S, Miyake T, Miyazaki Y, Hamamoto K, Masuda M, Takahashi H, Nomura S, Fukuhara S. Expression of functional tissue factor on small vesicles of lipopolysaccharide-stimulated human vascular endothelial cells. Thromb Haemost. 1997;(suppl):203. Abstract.
45. Taylor F Jr, Chang A, Ruf W, Morrissey JH, Hinshaw L, Catlett R, Blick K, Edgington TS. Lethal E coli septic shock is prevented by blocking tissue factor with monoclonal antibody. Circ Shock. 1991;33:127-134.
46. Rao LV. Tissue factor as a tumor procoagulant. Cancer Metastasis Rev. 1992;11:249-266.
47. Wilcox JN, Smith KM, Schwartz SM, Gordon D. Localization of tissue factor in the normal vessel wall and in the atherosclerotic plaque. Proc Natl Acad Sci U S A. 1989;86:2839-2843.
48. Bauters C, Asahara T, Zheng LP, Takeshita S, Bunting S, Ferrara N, Symes JF, Isner JM. Site-specific therapeutic angiogenesis after systemic administration of vascular endothelial growth factor. J Vasc Surg. 1995; 21:314-324.
49. Asahara T, Bauters C, Pastore C, Kearney M, Rossow S, Bunting S, Ferrara N, Symes JF, Isner JM. Local delivery of vascular endothelial growth factor accelerates reendothelialization and attenuates intimal hyperplasia in balloon-injured rat carotid artery. Circulation. 1995;91: 2793-2801.